Shanghai Fosun Pharmaceutical (Group) (SFOSF) Stock Price, News & Analysis

Company Overview

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based pharmaceutical and healthcare company engaged in research and development, manufacturing, distribution and retail of medicines and healthcare products. Founded in 1994 and headquartered in Shanghai, the company serves patients and healthcare providers through an integrated pharmaceutical platform.

Its product portfolio includes prescription medicines, over-the-counter products, vaccines, diagnostics and medical devices. Fosun Pharma focuses on therapeutic areas such as oncology, anti-infective treatments, cardiovascular and cerebrovascular diseases, central nervous system disorders, metabolic conditions and immune-related diseases. The company also develops and supplies biological products and specialty medicines.

Fosun Pharma operates primarily in China and has expanded its commercial and manufacturing activities internationally through subsidiaries, partnerships and product registrations in overseas markets. Its business includes pharmaceutical production, healthcare services and medical technology, supporting a broad presence across the healthcare value chain.

Key Stats

• Today's Range: $2.45 to $2.45
• 50-Day Range: $1.93 to $2.45
• 52-Week Range: $1.93 to $3.50
• Volume: N/A
• Average Volume: 1,375 shs
• Market Capitalization: N/A
• P/E Ratio: 2.09
• Dividend Yield: 11.02%
• Price Target: N/A
• Consensus Rating: N/A

Shanghai Fosun Pharmaceutical (Group) Stock Analysis - MarketRank™

Shanghai Fosun Pharmaceutical (Group) scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Shanghai Fosun Pharmaceutical (Group).

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Shanghai Fosun Pharmaceutical (Group) is 2.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.93.

Price to Earnings Ratio vs. Sector

The P/E ratio of Shanghai Fosun Pharmaceutical (Group) is 2.09, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.65.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Shanghai Fosun Pharmaceutical (Group) has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Shanghai Fosun Pharmaceutical (Group) has recently increased by 18.23%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Shanghai Fosun Pharmaceutical (Group) pays a meaningful dividend of 1.21%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Shanghai Fosun Pharmaceutical (Group) does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Shanghai Fosun Pharmaceutical (Group) is 23.08%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Shanghai Fosun Pharmaceutical (Group) this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Shanghai Fosun Pharmaceutical (Group) insiders have not sold or bought any company stock.

Percentage Held by Institutions

4.64% of the stock of Shanghai Fosun Pharmaceutical (Group) is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:SFOSF
• CIK: N/A
• Web: www.fosunpharma.com
• Phone: 86-21-3398-7000
• Fax: N/A
• Employees: 40,603
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 2.09
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A